Loading…
eXoZymes, Inc. is projected to rise to $6.08 by 2027, a +32% move from its current price of $4.60. EXOZ is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $4.39 | $4.60 | $4.82 | 0.00% |
| Aug 6 | $4.31 | $4.60 | $4.91 | -0.01% |
| Aug 7 | $4.25 | $4.60 | $4.98 | -0.01% |
| Aug 8 | $4.19 | $4.60 | $5.04 | -0.02% |
| Aug 9 | $4.15 | $4.60 | $5.10 | -0.02% |
| Aug 10 | $4.11 | $4.60 | $5.15 | -0.03% |
| Aug 11 | $4.07 | $4.60 | $5.19 | -0.03% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.07 | $4.60 | $5.19 | -0.03% |
| Week 2 | $3.87 | $4.60 | $5.46 | -0.06% |
| Week 3 | $3.72 | $4.60 | $5.68 | -0.09% |
| Week 4 | $3.60 | $4.59 | $5.86 | -0.12% |
| Week 5 | $3.50 | $4.59 | $6.03 | -0.15% |
| Week 6 | $3.41 | $4.59 | $6.19 | -0.18% |
| Week 7 | $3.33 | $4.59 | $6.34 | -0.21% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
eXoZymes, Inc. operates as a development stage biotechnology company focused on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company is categorized in Healthcare and has a history that includes a name change from Invizyne Technologies, Inc.
to eXoZymes, Inc. in February 2025. It was incorporated in 2014 and is headquartered in Monrovia, California.
EXOZ is the stock with a current price of $4.70 and a market capitalization of $43.62M, ranking 4514. The stock sits within a broader price trajectory described by a multi-year forecast that begins with a 2026 range of $4.70 to $6.31 (avg $4.70; ROI 0; sentiment NEUTRAL) and expands to higher prices in later years. This foreseen path includes a 2026 min of $4.70, a 2026 avg of $4.70, and a 2026 max of $6.31, establishing an initial baseline for later upside.
A major floor 62.0% below — a decisive break under it would weaken the trend.
The nearest floor, 4.3% below — buyers have tended to step in here.
The nearest ceiling, 84.8% above — a clean break opens room to run.
A major ceiling 154.3% above — clearing it would confirm fresh momentum.
Key EXOZ support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of EXOZ market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.52 | Buy | $4.63 | Sell |
| MA 10 | $4.81 | Sell | $4.95 | Sell |
| MA 20 | $5.86 | Sell | $5.66 | Sell |
| MA 50 | $7.45 | Sell | $7.01 | Sell |
| MA 100 | $8.36 | Sell | $8.15 | Sell |
| MA 200 | $10.20 | Sell | $9.37 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 29.10 | Buy |
| Stoch RSI (14) | 29.85 | Neutral |
| CCI (20) | -76.60 | Neutral |
| Williams %R (14) | -90.38 | Info |
| MACD (12,26,9) | -0.06 | Sell |
| ROC (12) | -24.02 | Sell |
| Bollinger %B (20,2) | 0.25 | Neutral |
| Stochastic %K (14) | 9.62 | Buy |
| TRIX (15) | -1.69 | Sell |
| Awesome (5,34) | -2.11 | Sell |
| Ultimate (7,14,28) | 26.58 | Buy |
| Momentum (10) | -1.37 | Sell |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 4.41 | Buy |
| ADX (14) | 34.66 | Sell |
| ATR (14) | 0.26 | Info |
Technically, the 30-day picture is NEUTRAL with RSI(14) at 30. The 50-day moving average is $8.08 and the 200-day moving average is $10.47. Near-term support is at $4.70 and resistance at $8.50.
The 30-day price range runs from $3.31 to $6.68, indicating limited upside within the near term and a potential baselining around the current price level near support.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.40 | $4.60 | $5.87 | 0% | Neutral | |
| $4.55 | $6.08 | $8.75 | +32% | Bullish | |
| $4.51 | $6.35 | $9.68 | +38% | Bullish | |
| $4.73 | $6.96 | $11.08 | +51% | Bullish | |
| $4.61 | $7.04 | $11.64 | +53% | Bullish | |
| $4.08 | $6.46 | $11.02 | +40% | Bullish | |
| $4.11 | $6.74 | $11.82 | +46% | Bullish | |
| $3.91 | $6.62 | $11.91 | +44% | Bullish | |
| $4.76 | $8.32 | $15.32 | +81% | Bullish | |
| $5.83 | $10.50 | $19.74 | +128% | Bullish | |
| $5.12 | $10.65 | $21.84 | +132% | Bullish | |
| $10.16 | $22.57 | $51.91 | +391% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $4.40 | $4.60 | $5.46 | +0.00% |
| September 2026 | $3.83 | $4.62 | $5.79 | +0.48% |
| October 2026 | $3.75 | $4.58 | $5.85 | -0.87% |
| November 2026 | $3.52 | $4.34 | $5.62 | -5.27% |
| December 2026 | $3.60 | $4.48 | $5.87 | +3.25% |
Click any year to see its month-by-month EXOZ forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, EXOZ could reach as high as $5.87, with a base case around $4.60 and support toward $4.40 — roughly 0% from $4.60. A consolidation phase looks the most probable path here.
Expect EXOZ to range from $4.55 to $8.75 through 2027. The $6.08 average target implies a +32% move from current prices. That is up +32% on the projected 2026 average. Momentum favours further upside here.
The EXOZ price prediction for 2028 points to an average of $6.35 (low $4.51, high $9.68) — a potential gain of +38% on today's $4.60. Buyers look set to stay in control over this stretch.
In 2029, EXOZ is projected to trade between $4.73 and $11.08, averaging $6.96 — a potential gain of +51% from today's $4.60. That is up +10% on the projected 2028 average. Momentum favours further upside here.
eXoZymes, Inc.'s 2030 outlook centres on $7.04, within a $4.61 to $11.64 range. That is up +1% on the projected 2029 average. That marks a +53% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, EXOZ could reach as high as $11.02, with a base case around $6.46 and support toward $4.08 — roughly +40% from $4.60. Momentum favours further upside here.
Expect EXOZ to range from $4.11 to $11.82 through 2032. The $6.74 average target implies a +46% move from current prices. That is up +4% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The EXOZ price prediction for 2033 points to an average of $6.62 (low $3.91, high $11.91) — a potential gain of +44% on today's $4.60. Momentum favours further upside here.
In 2034, EXOZ is projected to trade between $4.76 and $15.32, averaging $8.32 — a potential gain of +81% from today's $4.60. That is up +26% on the projected 2033 average. Buyers look set to stay in control over this stretch.
eXoZymes, Inc.'s 2035 outlook centres on $10.50, within a $5.83 to $19.74 range. That is up +26% on the projected 2034 average. That marks a +128% change versus current levels. Momentum favours further upside here.
By 2040, EXOZ could reach as high as $21.84, with a base case around $10.65 and support toward $5.12 — roughly +132% from $4.60. Buyers look set to stay in control over this stretch.
Expect EXOZ to range from $10.16 to $51.91 through 2050. The $22.57 average target implies a +391% move from current prices. That is up +112% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in EXOZ today (≈ 217.391304 EXOZ) could be worth
$4,906.45
+$3,906.45 (+391%) by 2050 · US Dollar
Based on the average projected EXOZ price of $22.57 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in EXOZwould be worth at today's price.
$1,000 invested in EXOZ on Jul 31, 2025 (≈ 99.009897 EXOZ) would be worth
$455.45
-$544.55 (-54.5%) today · 0.46× · US Dollar
Based on a EXOZ entry price of $10.1 vs. today's $4.6.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.71 | $976.65 | -2.3% |
| 1 month ago | $8.5 | $541.18 | -45.9% |
| 3 months ago | $9.75 | $471.79 | -52.8% |
| 6 months ago | $10.66 | $431.52 | -56.8% |
| 1 year ago | $10.1 | $455.45 | -54.5% |
| All time (1.7y) ago | $8.65 | $531.79 | -46.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our EXOZ forecast.
Our base-case forecast reaches $9.20 around 2035.
Implied market cap at $9.20: $85.39M
The multi-year forecast shows a bullish outlook across many years. In 2027 the average price is projected at $6.47 with a max of $9.61 and a 37.6% ROI; sentiment is BULLISH. In 2028 the average is $6.63 (max $10.51, ROI 41.2%), with a continued BULLISH stance.
For 2029, the average is $7.52 (max $12.52, ROI 60%). In 2030 the average is $7.46 (max $12.93, ROI 58.8%), still BULLISH. The trajectory continues through 2031 ($6.57 average, $11.79 max, 39.8% ROI), 2032 ($7.09 average, $13.11 max, 50.8% ROI), and 2033 ($6.75 average, $12.84 max, 43.7% ROI).
The forecast shows notable upside in 2034 ($8.82 avg, $17.20 max, 87.7% ROI) and 2035 ($11.65 avg, $23.25 max, 147.9% ROI), with ongoing BULLISH sentiment. By 2040 the average is $11.01 (max $24.15, ROI 134.3%), and by 2050 the average reaches $24.72 (max $56.85, ROI 425.9%), all with a BULLISH stance. These are estimates and not guarantees, reflecting potential upside under the given scenarios but subject to market and company-specific dynamics.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $7.46 with a min of $4.62 and a max of $12.93, and a projected ROI of 58.8% with a BULLISH sentiment.
Forecasts show bullish sentiment in 2027 through 2050, with positive ROIs such as 37.6% in 2027, 41.2% in 2028, 60% in 2029, 58.8% in 2030, and up to 425.9% by 2050, though these figures are estimates and not guarantees.
The 2050 forecast maximum is $56.85, with an average of $24.72 and a ROI of 425.9%, indicating a path that could exceed $50 under the max scenario.
The current price is $4.70.
The market capitalization is $43.62M.
eXoZymes, Inc. Community Discussion
0Share your eXoZymes, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.